ALYSON DYKES: Open Payments
NPI 1205422086 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$932 in 11 payments from 9 companies in 2025. Trend: 2023 $141 · 2024 $523 · 2025 $932
Food & beverage: $932
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 2 | $190 |
| Abbott Laboratories | 1 | $162 |
| Amgen Inc. | 1 | $129 |
| GlaxoSmithKline, LLC. | 1 | $120 |
| Tris Pharma Inc | 1 | $110 |
| Neurocrine BioSciences, Inc. | 1 | $96 |
| SANOFI-AVENTIS U.S. LLC | 1 | $61 |
| ABBVIE INC. | 2 | $49 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
Products named: Korlym, FREESTYLE LIBRE 3, SHINGRIX, Dyanavel XR, INGREZZA, TZIELD, BOTOX, Dysport.
Industry payments across MO — which companies pay providers there.
